The FDA has granted accelerated approval to Telisotuzumab vedotin for the treatment of patients with locally advanced or metastatic, nonsquamous non-small cell lung cancer with high c-MET protein overexpression. This approval is…
Heart-Sparing Technique in Lung Cancer Radiotherapy
A new study has been presented at ESTRO 2025 introducing RAPID-RT study. It utilizes an innovative rapid-learning approach to evaluate the impact of treatment modifications in radiotherapy. It offers a more inclusive…
Origins of Common Lung Cancer Linked to Smoking Discovered
A new study has been conducted in mice and humans by researchers at UCL, the Wellcome Sanger Institute and the University of Cambridge. It has been published in Science. This study found…
Lung Cancer Screening Is Beneficial For Non-Smokers As Well
Generally, lung cancer screening is targeted for smokers but an increased instances of the disease requires it among non-smokers as well. A new study has been published in JAMA and it reveals…
Understanding The Stage 0 Lung Cancer
Stage 0 lung cancer is that stage of lung cancer where cancer is only present in the lining layer of the airways. At this stage, the cancer has not spread to other…
Study: Diet Linked to Lung Cancer Development
When we thought of lung cancer risk, the first thing that comes to our mind is smoking and then air pollution. Time and again studies are being conducted. The researchers have found…
AstraZeneca Study Finds AI Potential in Lung Cancer
Global pharmaceutical company, AstraZeneca, has presented a recent study at the European Lung Cancer Congress 2025 highlighting the potential of Artificial Intelligence in improving lung cancer risk detection. It found that AI-integrated…
Study: Tagrisso As Backbone Therapy for Lung Cancer
Lung cancer remains the leading cause of cancer-related deaths worldwide. It is broadly classified into small cell lung cancer and non-small cell lung cancer. The latter accounts for about 80% of the…